Biobeat

Petah Tikva, Israel · Founded 2014 · Privately Held (backing)

Developer of a wearable remote patient monitoring device designed to measure vital signs using wireless, non-invasive, and medical-grade technology. Biobeat is based in Petah Tikva, Israel and was founded in 2014. Its last reported valuation was $103 million in May 2024. It has raised $71.8 million.

Last reported valuation
$102.7M
Oct 2026
Priced at
—
Total raised
$71.8M
Last round
—

Who backs Biobeat?

15 investors
InvestorType
OrbiMedGrowth equity
Ally Bridge GroupGrowth equity
and VenturesVenture capital
Elevage Medical Technologies—
ARC Innovation Center—
BestBuy Health—
BeyondBio (Isarel)—
Division of Research—
Florida-Israel Business Accelerator—
IAGi—
+ 5 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Biobeat investors

15 investors are on record for Biobeat, including OrbiMed, Ally Bridge Group, and Ventures and Elevage Medical Technologies.

Free account
More of Biobeat with a free account
  • ·The complete investor list: 15 names
  • ·Watch Biobeat: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 15 firms already write checks for companies like Biobeat. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View